Dyslipidemia: genes and variants
Explore variant evidence for Dyslipidemia across 1 analyzed protein (LDLR). Linked ClinVar records include 32 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 11 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Dyslipidemia
LDLR: Low-density lipoprotein receptor
It removes ApoB-containing LDL particles from the circulation through receptor-mediated endocytosis, especially in hepatocytes. Loss-of-function variants are the most common cause of familial hypercholesterolemia and lead to lifelong LDL elevation and premature atherosclerotic disease.
32 ClinVar pathogenic / likely pathogenic and 17 uncertain variants in LDLR have source records linked to Dyslipidemia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Dyslipidemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LDLR C377Y | 377 | EGF-like 2 | Pathogenic / likely pathogenic (★★) |
| LDLR D139E | 139 | LDL-receptor class A 3 | Pathogenic / likely pathogenic (★★) |
| LDLR C197Y | 197 | LDL-receptor class A 5 | Pathogenic / likely pathogenic (★★) |
| LDLR C209Y | 209 | LDL-receptor class A 5 | Pathogenic / likely pathogenic (★★) |
| LDLR Q254P | 254 | LDL-receptor class A 6 | Pathogenic / likely pathogenic (★★) |
| LDLR D307E | 307 | LDL-receptor class A 7 | Pathogenic / likely pathogenic (★★) |
| LDLR C313Y | 313 | LDL-receptor class A 7 | Pathogenic / likely pathogenic (★★) |
| LDLR C329Y | 329 | EGF-like 1 | Pathogenic / likely pathogenic (★★) |
| LDLR C368R | 368 | EGF-like 2 | Pathogenic / likely pathogenic (★★) |
| LDLR G373D | 373 | EGF-like 2 | Pathogenic / likely pathogenic (★★) |
| LDLR C104Y | 104 | LDL-receptor class A 2 | Pathogenic / likely pathogenic (★★) |
| LDLR D172N | 172 | LDL-receptor class A 4 | Pathogenic / likely pathogenic (★★) |
| LDLR C173W | 173 | LDL-receptor class A 4 | Pathogenic / likely pathogenic (★★) |
| LDLR D178E | 178 | LDL-receptor class A 4 | Pathogenic / likely pathogenic (★★) |
| LDLR D266E | 266 | LDL-receptor class A 6 | Pathogenic / likely pathogenic (★★) |
| LDLR Y375C | 375 | EGF-like 2 | Pathogenic / likely pathogenic (★★) |
| LDLR L401V | 401 | LDL-receptor class B 1 | Pathogenic / likely pathogenic (★★) |
| LDLR R416W | 416 | LDL-receptor class B 1 | Pathogenic / likely pathogenic (★★) |
| LDLR G549D | 549 | LDL-receptor class B 4 | Pathogenic / likely pathogenic (★★) |
| LDLR P685L | 685 | EGF-like 3 | Pathogenic / likely pathogenic (★★) |
| LDLR V797M | 797 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| LDLR V797L | 797 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| LDLR C82S | 82 | LDL-receptor class A 2 | Pathogenic / likely pathogenic (★★) |
| LDLR C121Y | 121 | LDL-receptor class A 3 | Pathogenic / likely pathogenic (★★) |
| LDLR C148S | 148 | LDL-receptor class A 4 | Pathogenic / likely pathogenic (★★) |
| LDLR C338Y | 338 | EGF-like 1 | Pathogenic / likely pathogenic (★★) |
| LDLR I451T | 451 | LDL-receptor class B 2 | Pathogenic / likely pathogenic (★★) |
| LDLR G565V | 565 | LDL-receptor class B 4 | Pathogenic / likely pathogenic (★★) |
| LDLR P608L | 608 | LDL-receptor class B 5 | Pathogenic / likely pathogenic (★★) |
| LDLR D131N | 131 | LDL-receptor class A 3 | Pathogenic / likely pathogenic (★★) |
| LDLR C377S | 377 | EGF-like 2 | Pathogenic / likely pathogenic (★) |
| LDLR Q660H | 660 | Extracellular | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Dyslipidemia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- EVE: 100 out of 100
- MetaSVM: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 97 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 96 out of 100
- AlphaMissense: 96 out of 100
- PolyPhen-2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 92 out of 100
- phyloP: 78 out of 100
- SpliceAI: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 38 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Familial hypercholesterolemia also has ClinVar records linked to LDLR variants; they fall mostly in different places as the Dyslipidemia variants (668 pathogenic / likely pathogenic).
- Homozygous familial hypercholesterolemia also has ClinVar records linked to LDLR variants; they fall partly in the same places as the Dyslipidemia variants (26 pathogenic / likely pathogenic).
Diseases related to Dyslipidemia
- Familial hypercholesterolemia, also linked to LDLR
- Homozygous familial hypercholesterolemia, also linked to LDLR
- Heart disease, also linked to LDLR
- Myocardial infarction, also linked to LDLR
Frequently asked questions
Which genes have records linked to Dyslipidemia?
This view contains 1 analyzed proteins: LDLR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 32 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 11 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 49 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center